SAFECODE DRUG TECHNOLOGIES CORP. Fees and Commissions (Deprecated 2018-01-31)
SAFECODE DRUG TECHNOLOGIES CORP. reported Fees and Commissions (Deprecated 2018-01-31) of -$92.56 thousand for the 31-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Notes
us-gaap:FeesAndCommissions · last filed 2013-08-13
- SAFECODE DRUG TECHNOLOGIES CORP. fees and commissions (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00.
- SAFECODE DRUG TECHNOLOGIES CORP. fees and commissions (deprecated 2018-01-31) for the quarter ending 2013-03-31 was -$92.56K.
- SAFECODE DRUG TECHNOLOGIES CORP. fees and commissions (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $0.00.
| Period end | Fees and Commissions (Deprecated 2018-01-31) 3 month | Fees and Commissions (Deprecated 2018-01-31) 6 month | Fees and Commissions (Deprecated 2018-01-31) 28 month | Fees and Commissions (Deprecated 2018-01-31) 31 month |
|---|---|---|---|---|
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$92.56K 10-Q · filed 2013-08-13 | -$92.56K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | -$92.56K 10-Q · filed 2013-05-10 | -$92.56K 10-Q · filed 2013-05-10 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 |